-Multiple tranche debt financing agreement provides Oncorus with access to up to $45 million-
-Use of proceeds intended to support completion of a GMP-compliant manufacturing facility in Andover, MA and the clinical development of its IV administered vRNA/LNP product candidate, ONCR-021, and other pipeline programs-
Read more at globenewswire.com